News|Slideshows|July 15, 2020

AHA Guidelines on Obesity for CVD Prevention: 5 Questions

Obesity is a primary risk factor for cardiovascular disease and can also be modified with comprehensive care. Test yourself on the AHA/ACC recommendations for that care.

FOCUS: Preventive Cardiology and Obesity

Obesity is a risk factor for nearly all forms of cardiovascular and cardiometabolic disease. In fact, the epidemic status of obesity in the United States has been identified as responsible for the rise in deaths from heart disease after 4 decades of steady decline.

Prevention and management of overweight and obesity is central to primary prevention of CVD. Test yourself on the most recent guidance from the American Heart Association/American College of Cardiology (AHA/ACC) on comprehensive interventions to treat patients with this chronic, relapsing disease.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

Latest CME

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person Event

Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

December 4, 2025

Virtual Event

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

December 19, 2025

In-Person + Virtual Event

GI Cancers Symposia

January 8, 2026

In-Person Event

23rd Annual Winter Lung Cancer Conference®

January 23-25, 2026

AHA Guidelines on Obesity for CVD Prevention: 5 Questions

FOCUS: Preventive Cardiology and Obesity

Obesity is a risk factor for nearly all forms of cardiovascular and cardiometabolic disease. In fact, the epidemic status of obesity in the United States has been identified as responsible for the rise in deaths from heart disease after 4 decades of steady decline.

Newsletter

Related Content

Aggressive Risk Factor Management Reduced Recurrent AF by Nearly Half After Catheter Ablation

Genitourinary Syndrome of Menopause (GSM): Clinical FAQ for Primary Care

Screening for Breast Cancer in Patients With Dense Breast Tissue: A Q&A With Donna Plecha, MD

US Obesity Rates Decline in Tandem With Rise in Use of GLP-1 RA, New Gallup Index Shows

TMS 2025: Regina Castaneda, MD, on Tirzepatide, Menopause, and Hormone Therapy

Latest CME

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

GI Cancers Symposia

23rd Annual Winter Lung Cancer Conference®

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

10th Annual Live Medical Crossfire®: Hematologic Malignancies

Annual Hematology Meeting: Preceding the 67th ASH Annual Meeting and Exposition

27th Annual International Lung Cancer Congress®

Community Collab: A Round Table Exploration of Effective Anesthesia with Vasoconstriction in Head and Neck Surgery

4th Annual International Congress on Pediatric Oncology

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

20th Annual New York Lung Cancers Symposium®

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

DSUI Urology on the Beach

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

23rd Annual School of Breast Oncology

26th Annual International Lung Cancer Congress

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Iowa

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | New York

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Minnesota

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | South Carolina

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Expert Perspectives on Technological Advances in Cataract Surgery

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Texas

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | West Virginia

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Tennessee

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Washington

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Homing in on the Role of PSMA in Prostate Cancer – Harnessing the Power of Precision Medicine Through Imaging and Therapy to Individualize Treatment Plans

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Louisiana

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Colorado

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Montana and Wyoming

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Breast Cancer Symposia in San Antonio